<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36115083</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-5069</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Epilepsy &amp; behavior : E&amp;B</Title><ISOAbbreviation>Epilepsy Behav</ISOAbbreviation></Journal><ArticleTitle>Long-term analysis of the effects of COVID-19 in people with epilepsy: Results from a multicenter on-line survey across the pandemic waves.</ArticleTitle><Pagination><StartPage>108900</StartPage><MedlinePgn>108900</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.yebeh.2022.108900</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1525-5050(22)00349-3</ELocationID><Abstract><AbstractText Label="PURPOSE">The worldwide pandemic caused by SARS-CoV-2 virus posed many challenges to the scientific and medical communities, including the protection and management of fragile populations. People with epilepsy (PWE) are a heterogenous group of subjects, with different treatment regimens and severity of symptoms. During the National lockdown, in Italy many patients with chronic conditions lost their regular follow-up program. The aim of this study was to investigate the impact of COVID-19 on their health status, from the start of the pandemic (March 2020) to July 2021 and one year later.</AbstractText><AbstractText Label="METHODS">We proposed an online questionnaire to subjects followed up at different epilepsy centers located in Milano, Monza &amp; Lodi, three of Lombardy, Northern Italy, the most affected areas by the pandemic. Survey evaluated age, sex, characteristics of patients, type of epilepsy and therapies, COVID-19 diagnosis, vaccines, sleep quality, and anxiety status.</AbstractText><AbstractText Label="RESULTS">Among 178 analyzed surveys, 37 individuals reported symptoms of COVID-19 in closed contacts, including 9 with molecular diagnosis and 16 PWE performing the nasopharyngeal swab with 3 positive cases. One year later, 35 individuals reported at least one symptom overlapping with those typical of COVID-19, 8 received COVID-19 diagnosis, among which 6 were positive for SARS-CoV-2 infection. According to the sleep quality scale assessment, most PWE (52.3%) had poor sleep quality. Assessing anxiety status, 32 (38.1%) had a pathological score.</AbstractText><AbstractText Label="CONCLUSION">In this multicenter study, we observed that PWE do not appear to be at a higher risk of severe COVID-19. It will be fundamental monitoring this group to assess possible differences in long-COVID-19 and/or neuro-COVID-19 prevalence. On the other hand, our survey confirmed the impact of the pandemic on anxiety and quality of sleep in PWE. Thus, it is important to promptly recognize and treat psychological distress in PWE, because it could be a risk factor in seizure aggravation and quality-of-life deterioration. Telemedicine appears to be a useful tool to support patients with chronic diseases, such as epilepsy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parodi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vigan&#xf2;</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ottaviano</LastName><ForeName>Emerenziana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massa</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Universit&#xe0; degli Studi di Milano, Milan, Italy; "Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borghi</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beretta</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epilepsy Center, ASST San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Francesco</LastName><ForeName>Jacopo C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Epilepsy Center, ASST San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badioni</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neurology Unit, ASST Lodi, Lodi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vignoli</LastName><ForeName>Aglaia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Universit&#xe0; degli Studi di Milano, Milan, Italy; Neuropsychiatry of Childhood and Adolescence, ASST GOM Niguarda, Ospedale Niguarda Ca' Granda, Milan, Italy. Electronic address: aglaia.vignoli@unimi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COV-EPI Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Epilepsy Behav</MedlineTA><NlmUniqueID>100892858</NlmUniqueID><ISSNLinking>1525-5050</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="Y">Epilepsy</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiseizure medications</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Epilepsy</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>18</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36115083</ArticleId><ArticleId IdType="pmc">PMC9404228</ArticleId><ArticleId IdType="doi">10.1016/j.yebeh.2022.108900</ArticleId><ArticleId IdType="pii">S1525-5050(22)00349-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hui D.S., I Azhar E., Madani T.A., Ntoumi F., Kock R., Dar O., et al. novel coronavirus outbreak in Wuhan. China Int J Infect Dis. 2020;91:264&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128332</ArticleId><ArticleId IdType="pubmed">31953166</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Novel Coronavirus(2019-nCoV) Situation Report, 22. 2020.</Citation></Reference><Reference><Citation>Zhu N.a., Zhang D., Wang W., Li X., Yang B.o., Song J., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data n.d. https://covid19.who.int/ (accessed May 30, 2021).</Citation></Reference><Reference><Citation>Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region. Italy JAMA. 2020;323(16):1574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250&#x2013;256. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The pathogenesis and treatment of the &#x2018;Cytokine Storm&#x2019;&#x2019; in COVID-19&#x2019;. J Infect. 2020;80:607&#x2013;613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghagoli G., Gallo Marin B., Katchur N.J., Chaves-Sell F., Asaad W.F., Murphy S.A. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care. 2021;34(3):1062&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358290</ArticleId><ArticleId IdType="pubmed">32661794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I., Rathore F.A. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8&#x2013;12. doi: 10.1016/j.jocn.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7200361</ArticleId><ArticleId IdType="pubmed">32409215</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohora D., Jain S., Tripathi M., Potschka H. COVID-19 and seizures: Is there a link? Epilepsia. 2020;61:1840&#x2013;1853. doi: 10.1111/epi.16656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.16656</ArticleId><ArticleId IdType="pmc">PMC7537056</ArticleId><ArticleId IdType="pubmed">32944929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda N. Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav. 2020;108:107122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174174</ArticleId><ArticleId IdType="pubmed">32361677</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA. Seizures associated with coronavirus infections 2020. doi: 10.1016/j.seizure.2020.05.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212943</ArticleId><ArticleId IdType="pubmed">32416567</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Larsen A., Gonzalez-Villar E., D&#xed;az-Maroto I., Layos-Romero A., Mart&#xed;nez-Mart&#xed;n &#xc1;., Alcahut-Rodriguez C., et al. Influence of the COVID-19 outbreak in people with epilepsy: analysis of a Spanish population (EPICOVID registry) Epilepsy Behav. 2020;112:107396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476448</ArticleId><ArticleId IdType="pubmed">32911299</ArticleId></ArticleIdList></Reference><Reference><Citation>Blecker S., Jones S.A., Petrilli C.M., Admon A.J., Weerahandi H., Francois F., et al. Hospitalizations for chronic disease and acute conditions in the time of COVID-19. JAMA Intern Med. 2021;181(2):269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7589070</ArticleId><ArticleId IdType="pubmed">33104158</ArticleId></ArticleIdList></Reference><Reference><Citation>Fesler J.R., Stanton S., Merner K., Ross L., McGinley M.P., Bena J., et al. Bridging the gap in epilepsy care: a single-center experience of 3700 outpatient tele-epilepsy visits. Epilepsia. 2020;61(8) doi: 10.1111/EPI.16619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/EPI.16619</ArticleId><ArticleId IdType="pubmed">32697361</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta P., Barrett W., Bentzinger M., Jasinski T., Jayagopal L.A., Mahoney A., et al. Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic. Epilepsy Behav. 2021;116:107740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8803629</ArticleId><ArticleId IdType="pubmed">33545652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca E., Quintana M., Lallana S., Luis Restrepo J., Abraira L., Santamarina E., et al. Epilepsy in time of COVID-19: a survey-based study. Acta Neurol Scand. 2020;142(6):545&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460986</ArticleId><ArticleId IdType="pubmed">32799337</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao X., Zhou D., Li Z., Zeng G., Hao N., Li E., et al. Severe psychological distress among patients with epilepsy during the COVID-19 outbreak in southwest China. Epilepsia. 2020;61(6):1166&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267575</ArticleId><ArticleId IdType="pubmed">32353184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda N., Kubota T. Psychological impact of the COVID-19 pandemic for patients with epilepsy: a systematic review and meta-analysis. Epilepsy Behav. 2021;124:108340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9760102</ArticleId><ArticleId IdType="pubmed">34600283</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashakori-Miyanroudi M., Souresrafil A., Hashemi P., Jafar Ehsanzadeh S., Farrahizadeh M., Behroozi Z. Prevalence of depression, anxiety, and psychological distress in patients with epilepsy during COVID-19: a systematic review. Epilepsy Behav. 2021;125:108410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586733</ArticleId><ArticleId IdType="pubmed">34781062</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielberger C.D., Gorsuch R.L., Lushene R.E. Consulting Psychologists Press; Polo Alto, CA: 1970. Manual for the State-Trait Anxiety Inventory.</Citation></Reference><Reference><Citation>Wright K.B. Researching internet-based populations: advantages and disadvantages of online survey research, online questionnaire authoring software packages, and web survey services. J Comput Commun. 2005;10(3)</Citation></Reference><Reference><Citation>Casassa C., Moss R., Goldenholz D.M. Epilepsy during the COVID-19 pandemic lockdown: a US population survey. Epileptic Disord. 2021;23:257&#x2013;267. doi: 10.1684/epd.2021.1259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/epd.2021.1259</ArticleId><ArticleId IdType="pmc">PMC8447384</ArticleId><ArticleId IdType="pubmed">33772512</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiners F., Sturm J., Bouw L.J.W., Wouters E.J.M. Sociodemographic factors influencing the use of eHealth in people with chronic diseases. Int J Environ Res Public Health. 2019;16(4):645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6406337</ArticleId><ArticleId IdType="pubmed">30795623</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitar H., Alismail S. The role of eHealth, telehealth, and telemedicine for chronic disease patients during COVID-19 pandemic: a rapid systematic review. Digital Health. 2021;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060773</ArticleId><ArticleId IdType="pubmed">33959378</ArticleId></ArticleIdList></Reference><Reference><Citation>Digital 2020 Italia &#x2013; We Are Social Italia n.d. https://wearesocial.com/it/digital-2020-italia.</Citation></Reference><Reference><Citation>Lanzone J., Cenci C., Tombini M., Ricci L., Tufo T., Piccioli M., et al. Glimpsing the impact of COVID19 lock-down on people with epilepsy: a text mining approach. Front Neurol. 2020;11 doi: 10.3389/fneur.2020.00870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00870</ArticleId><ArticleId IdType="pmc">PMC7466558</ArticleId><ArticleId IdType="pubmed">32973656</ArticleId></ArticleIdList></Reference><Reference><Citation>Trivisano M., Specchio N., Pietrafusa N., Calabrese C., Ferretti A., Ricci R., et al. Impact of COVID-19 pandemic on pediatric patients with epilepsy &#x2013; the caregiver perspective. Epilepsy Behav. 2020;113:107527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683298</ArticleId><ArticleId IdType="pubmed">33242768</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhotani A., Siddiqui M.I., Almuntashri F., Baothman R. The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy. Epilepsy Behav. 2020;112 doi: 10.1016/J.YEBEH.2020.107323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.YEBEH.2020.107323</ArticleId><ArticleId IdType="pmc">PMC7359799</ArticleId><ArticleId IdType="pubmed">32712565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C., Meng H., Zhu Y., Yao L., Lian Y., Zhu Y., et al. Correlation of seizure increase and COVID-19 outbreak in adult patients with epilepsy: findings and suggestions from a nationwide multi-centre survey in China. Seizure. 2021;88:102&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9056154</ArticleId><ArticleId IdType="pubmed">33839561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalilani L., Sun X., Pelgrims B., Noack-Rink M., Villanueva V. The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis. Epilepsia. 2018;59:2179&#x2013;2193. doi: 10.1111/epi.14596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.14596</ArticleId><ArticleId IdType="pubmed">30426482</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K.e., Zou R., Cui W., Li M., Wang X., Dong J., et al. Clinical HDAC inhibitors are effective drugs to prevent the entry of SARS-CoV2. ACS Pharmacol Transl Sci. 2020;3(6):1361&#x2013;1370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7671100</ArticleId><ArticleId IdType="pubmed">34778724</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitt B., Sutton N.R., Wang Z., Goonewardena S.N., Holinstat M. Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19. Eur J Pharmacol. 2021;898 doi: 10.1016/j.ejphar.2021.173988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.173988</ArticleId><ArticleId IdType="pmc">PMC7923868</ArticleId><ArticleId IdType="pubmed">33667455</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde Blanco E., Manzanares I., Centeno M., Khawaja M., Betr&#xe1;n O., Donaire A., et al. Epilepsy and lockdown: a survey of patients normally attending a Spanish centre. Acta Neurol Scand. 2021;143(2):206&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646661</ArticleId><ArticleId IdType="pubmed">32990951</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Fern&#xe1;ndez-D&#xed;az E., S&#xe1;nchez-Larsen &#xc1;., Layos-Romero A., Garc&#xed;a-Garc&#xed;a J., et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezudo-Garc&#xed;a P., Ciano-Petersen N.L., Mena-V&#xe1;zquez N., Pons-Pons G., Castro-S&#xe1;nchez M.V., Serrano-Castro P.J. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology. 2020;95:e1417&#x2013;e1425. doi: 10.1212/WNL.0000000000010033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010033</ArticleId><ArticleId IdType="pubmed">32554773</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrini S., Koepp M.J., Gandhi S., Rickman H.M., Shin G.Y., Houlihan C.F., et al. Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy. Epilepsy Behav. 2021;115 doi: 10.1016/J.YEBEH.2020.107602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.YEBEH.2020.107602</ArticleId><ArticleId IdType="pmc">PMC7643621</ArticleId><ArticleId IdType="pubmed">33279440</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata T., Bisulli F., Arzimanoglou A., Rocamora R. Did the COVID-19 pandemic silence the needs of people with epilepsy? Epileptic Disord. 2020;22:439. doi: 10.1684/EPD.2020.1175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/EPD.2020.1175</ArticleId><ArticleId IdType="pmc">PMC7537265</ArticleId><ArticleId IdType="pubmed">32759092</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Emami A., Akbari A., Javanmardi F. COVID-19 presentations and outcome in patients with epilepsy. Acta Neurol Scand. 2021;143:624&#x2013;628. doi: 10.1111/ANE.13404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ANE.13404</ArticleId><ArticleId IdType="pmc">PMC8014655</ArticleId><ArticleId IdType="pubmed">33590880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstein D., Noyman I., Fahoum F., Herskovitz M., Linder I., Ben Zeev B., et al. Treating epilepsy patients with investigational anti-COVID-19 drugs: recommendations by the Israeli chapter of the ILAE. Isr Med Assoc J. 2020;11:665&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pubmed">33249784</ArticleId></ArticleIdList></Reference><Reference><Citation>Alotaibi F., Althani Z., Aljaafari D., Tayeb H.O., Baarmah D., Aljalal N., et al. Saudi epilepsy society consensus on epilepsy management during the covid-19 pandemic. Neurosciences. 2020;25(3):222&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015472</ArticleId><ArticleId IdType="pubmed">32683406</ArticleId></ArticleIdList></Reference><Reference><Citation>von Oertzen T.J., Macerollo A., Leone M.A., Beghi E., Crean M., Oztuk S., et al. EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol. 2021;28(1):7&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675361</ArticleId><ArticleId IdType="pubmed">33058321</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. People with Certain Medical Conditions | CDC n.d. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (accessed December 11, 2021).</Citation></Reference><Reference><Citation>Massoud F., Ahmad S.F., Hassan A.M., Alexander K.J., Al&#x2013;Hashel J., Arabi M. coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): a cross-sectional study. Seizure. 2021;92:2&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343389</ArticleId><ArticleId IdType="pubmed">34391030</ArticleId></ArticleIdList></Reference><Reference><Citation>Assenza G., Lanzone J., Brigo F., Coppola A., Di Gennaro G., Di Lazzaro V., et al. Epilepsy care in the time of COVID-19 pandemic in Italy: risk factors for seizure worsening. Front Neurol. 2020;11 doi: 10.3389/fneur.2020.00737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00737</ArticleId><ArticleId IdType="pmc">PMC7350269</ArticleId><ArticleId IdType="pubmed">32719655</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross J.H., Kwon C.S., Asadi-Pooya A.A., Balagura G., G&#xf3;mez-Iglesias P., Guekht A., et al. Epilepsy care during the COVID-19 pandemic. Epilepsia. 2021;62:2322&#x2013;2332. doi: 10.1111/EPI.17045/FORMAT/PDF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/EPI.17045/FORMAT/PDF</ArticleId><ArticleId IdType="pmc">PMC8652685</ArticleId><ArticleId IdType="pubmed">34428314</ArticleId></ArticleIdList></Reference><Reference><Citation>Members of the Digital Technologies, Web and Social Media Study, Group of the Italian Society of Neurology. Letter to the Editor 2020. doi: 10.1016/j.yebeh.2020.107164.</Citation></Reference><Reference><Citation>von Wrede R., Moskau-Hartmann S., Baumgartner T., Helmstaedter C., Surges R. Counseling of people with epilepsy via telemedicine: experiences at a German tertiary epilepsy center during the COVID-19 pandemic. Epilepsy Behav. 2020;112:107298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422810</ArticleId><ArticleId IdType="pubmed">32801068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda N. Decision making on telemedicine for patients with epilepsy during the Coronavirus Disease 2019 (COVID-19) crisis. Front Neurol. 2020;11:722. doi: 10.3389/FNEUR.2020.00722/BIBTEX.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2020.00722/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC7344218</ArticleId><ArticleId IdType="pubmed">32714276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloem B.R., Dorsey E.R., Okun M.S. The Coronavirus Disease 2019 crisis as catalyst for telemedicine for chronic neurological disorders. JAMA Neurol. 2020;77:927&#x2013;928. doi: 10.1001/JAMANEUROL.2020.1452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANEUROL.2020.1452</ArticleId><ArticleId IdType="pubmed">32329796</ArticleId></ArticleIdList></Reference><Reference><Citation>Magesh S., John D., Li W.T., Li Y., Mattingly-app A., Jain S., et al. Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic-review and meta-analysis. JAMA Netw Open. 2021;4(11):e2134147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586903</ArticleId><ArticleId IdType="pubmed">34762110</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R., Rahmandad H., Gupta M., Digennaro C., Ghaffarzadegan N., Amini H., et al. Weather, air pollution, and SARS-CoV-2 transmission: a global analysis. Lancet Planet Heal. 2021;5:e671&#x2013;e680. doi: 10.1016/S2542-5196(21)00202-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2542-5196(21)00202-3</ArticleId><ArticleId IdType="pmc">PMC8497024</ArticleId><ArticleId IdType="pubmed">34627471</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda N. Epilepsy and COVID-19: Updated evidence and narrative review. Epilepsy Behav. 2021;116 doi: 10.1016/J.YEBEH.2021.107785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.YEBEH.2021.107785</ArticleId><ArticleId IdType="pmc">PMC7805398</ArticleId><ArticleId IdType="pubmed">33515934</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore C., Baheti N., Bansal A.R., Jabeen S.A., Gopinath S., Jagtap S., et al. Impact of COVID-19 pandemic on epilepsy practice in India: a tripartite survey. Seizure. 2021;86:60&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837209</ArticleId><ArticleId IdType="pubmed">33550135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosak M., Mazurkiewicz I., W&#x119;&#x17c;yk K., S&#x142;owik A., Turaj W. COVID-19 among patients with epilepsy: Risk factors and course of the disease. Epilepsy Behav. 2021;120 doi: 10.1016/J.YEBEH.2021.107996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.YEBEH.2021.107996</ArticleId><ArticleId IdType="pmc">PMC8064834</ArticleId><ArticleId IdType="pubmed">33957438</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>